UK’s Johnson Matthey (JM) has signed a definitive agreement to sell 100% of its Medical Device Components (MDC) business to Montagu Private Equity for $700 million (£550...
Johnson Matthey (JM) looks back at a legacy of 200+ years. Established in 1817, the London, England-based chemical company reported annual revenues of about €18 billion...
20.07.2011
- Autocatalysts and precious metals maker Johnson Matthey reported Tuesday a strong growth in its first-quarter profit and sales, benefited principally from higher demand for...
27.01.2010
- Johnson Matthey has reported that it had seen the beginnings of recovery in many of its key markets in the last three months of 2009. Sales for the fiscal third quarter excluding...
